Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cellectis amends follow-on

    Cellectis S.A.(Euronext:ALCLS), Paris, France Business: Gene/Cell therapy, Genomics Date announced: 2015-03-18 Type: Follow-on To be raised: Up to $148.2 million Shares: 3.5 million Price Prior: EUR12.53 Underwriters: …

    Published on 3/23/2015
  • Viking Therapeutics amends IPO

    Viking Therapeutics Inc., San Diego, Calif. Business: Endocrine/Metabolic, Musculoskeletal, Hematology Date announced: 2015-03-02 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: Laidlaw Overallotment: …

    Published on 3/23/2015
  • Admedus completes placing

    Admedus Ltd.(ASX:AHZ), Perth, Australia Business: Transplant, Infectious Date completed: 2015-03-18 Type: Placing Raised: A$12 million ($9.2 million) Shares: 171.5 million Price: A$0.07 Shares after offering: 1.6 …

    Published on 3/23/2015
  • Alize Pharma completes venture financing

    Alize Pharma, Lyon, France Business: Endocrine/Metabolic Date completed: 2015-03-17 Type: Venture financing Raised: EUR1.8 million ($1.9 million) Investors: Sofimac; Octalfa S.A.S.; Sham; Rhone Alpes Creation; Credit …

    Published on 3/23/2015
  • Anthera completes follow-on

    Anthera Pharmaceuticals Inc.(NASDAQ:ANTH), Hayward, Calif. Business: Autoimmune, Cardiovascular Date completed: 2015-03-18 Type: Follow-on Raised: $25 million Shares: 5.6 million Price: $4.50 Shares after offering: 28.6…

    Published on 3/23/2015
  • Assembly Biosciences completes follow-on

    Assembly Biosciences Inc.(NASDAQ:ASMB), New York, N.Y. Business: Gastrointestinal, Genitourinary, Infectious Date completed: 2015-03-19 Type: Follow-on Raised: $75 million Shares: 5.6 million Price: $13.50 Shares after …

    Published on 3/23/2015
  • Concert Pharmaceuticals completes follow-on

    Concert Pharmaceuticals Inc.(NASDAQ:CNCE), Lexington, Mass. Business: Neurology, Inflammation, Renal Date completed: 2015-03-19 Type: Follow-on Raised: $50 million Shares: 3.3 million Price: $15.15 Shares after offering…

    Published on 3/23/2015
  • CureVac completes venture financing

    CureVac GmbH, Tuebingen, Germany Business: Cancer, Infectious Date completed: 2015-03-05 Type: Venture financing Raised: $76 million Investors: Bill & Melinda Gates Foundation; dievini Hopp BioTech

    Published on 3/23/2015
  • Eagle Pharmaceuticals completes follow-on

    Eagle Pharmaceuticals Inc.(NASDAQ:EGRX), Woodcliff Lake, N.J. Business: Cardiovascular, Cancer Date completed: 2015-03-17 Type: Follow-on Raised: $50 million Shares: 1.2 million Price: $42 Shares after offering: 15.2 …

    Published on 3/23/2015
  • Epizyme completes follow-on

    Epizyme Inc.(NASDAQ:EPZM), Cambridge, Mass. Business: Cancer Date completed: 2015-03-18 Type: Follow-on Raised: $124.5 million Shares: 6 million Price: $20.75 Shares after offering: 40.5 million Underwriters: Leerink …

    Published on 3/23/2015
  • Esperion completes follow-on

    Esperion Therapeutics Inc.(NASDAQ:ESPR), Plymouth, Mich. Business: Endocrine/Metabolic, Cardiovascular Date completed: 2015-03-18 Type: Follow-on Raised: $175 million Shares: 1.8 million Price: $100 Shares after …

    Published on 3/23/2015
  • Helix completes private placement of common stock and warrants

    Helix BioPharma Corp.(TSX:HBP), Aurora, Ontario Business: Cancer, Drug delivery, Proteomics Date completed: 2015-03-16 Type: Private placement of common stock and warrants Raised: C$5.2 million ($4.1 million) Price: C$1…

    Published on 3/23/2015
  • Lixte completes private placement of convertible preferred stock

    Lixte Biotechnology Holdings Inc.(OTCQB:LIXT), East Setauket, N.Y. Business: Cancer Date completed: 2015-03-18 Type: Private placement of convertible preferred stock Raised: $1.8 million Shares: 175,000 Price: $10 …

    Published on 3/23/2015
  • Navidea completes private placement of convertible preferred stock and warrants

    Navidea Biopharmaceuticals Inc.(NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Date completed: 2015-03-16 Type: Private placement of convertible preferred stock and warrants Raised: $500,000 Shares: 10 Price: $50,000 …

    Published on 3/23/2015
  • New Oncology completes venture financing

    NEO New Oncology AG, Cologne, Germany Business: Diagnostic Date completed: 2015-03-17 Type: Venture financing Raised: Not disclosed Investors: Existing investors; new investors Note: The amount raised is not disclosed.

    Published on 3/23/2015
  • Nimbus Therapeutics completes venture financing

    Nimbus Therapeutics LLC, Cambridge, Mass. Business: Computational chemistry/biology, Cancer, Endocrine/Metabolic Date completed: 2015-03-18 Type: Venture financing Raised: $43 million Investors: Pfizer Venture …

    Published on 3/23/2015
  • Nordic Nanovector completes IPO

    Nordic Nanovector ASA(OSE:NANO), Oslo, Norway Business: Cancer Date completed: 2015-03-20 Type: IPO Raised: NOK500 million ($60.9 million) Shares: 15.6 million Price: NOK32 Shares after offering: 42.2 million …

    Published on 3/23/2015
  • Retrophin completes follow-on

    Retrophin Inc.(NASDAQ:RTRX), New York, N.Y. Business: Renal, Musculoskeletal, Pulmonary Date completed: 2015-03-19 Type: Follow-on Raised: $130 million Shares: 6.8 million Price: $19 Shares after offering: 32.9 million …

    Published on 3/23/2015
  • Serenus completes venture financing

    Serenus Biotherapeutics Inc., San Francisco, Calif. Business: Infectious Date completed: 2015-03-03 Type: Venture financing Raised: $18 million Investor: Malin

    Published on 3/23/2015
  • Spectral Medical completes private placement

    Spectral Medical Inc.(TSX:EDT; OTCQX:EDTXF), Toronto, Ontario Business: Diagnostic Date completed: 2015-03-16 Type: Private placement Raised: C$5 million ($3.9 million) Shares: 9 million Price: C$0.55 Shares after …

    Published on 3/23/2015
  • Tekmira completes follow-on

    Tekmira Pharmaceuticals Corp.(NASDAQ:TKMR), Burnaby, B.C. Business: Cancer, Drug delivery Date completed: 2015-03-20 Type: Follow-on Raised: $151.9 million Shares: 7.5 million Price: $20.25 Shares after offering: 54.1 …

    Published on 3/23/2015
  • Tribute Pharmaceuticals completes warrant exercise

    Tribute Pharmaceuticals Canada Inc.(OTCQX:TBUFF; TSX-V:TRX), Milton, Ontario Business: Autoimmune, Genitourinary, Diagnostic Date completed: 2015-03-19 Type: Warrant exercise Raised: $2.7 million Shares: 5.4 million …

    Published on 3/23/2015
  • ADMA financial update

    ADMA Biologics Inc.(NASDAQ:ADMA), Ramsey, N.J. Business: Hematology, Infectious Date announced: 2015-03-18 Note: ADMA raised $1.5 million through the sale of 183,750 shares at $8 to cover the overallotment from its …

    Published on 3/23/2015
  • CollabRx financial update

    CollabRx Inc.(NASDAQ:CLRX), San Francisco, Calif. Business: Bioinformatics Date announced: 2015-03-03 Note: CollabRx raised $450,000 through the sale of 354,330 shares at $1.27 to cover the overallotment from its Feb. …

    Published on 3/23/2015
  • Dicerna financial update

    Dicerna Pharmaceuticals Inc.(NASDAQ:DRNA), Watertown, Mass. Business: Cancer Date announced: 2015-03-12 Note: Dicerna established an at-the-market program to sell up to 2.5 million shares of its common stock. Cowen is …

    Published on 3/23/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993